Page 111 - product-manual
P. 111

TM/MC  TM/MC
             PHARMACOLOGICAL ACTIVITIES - TOXICOLOGY - DRUG INTERACTIONS





        Crataeva nurvala (Three-Leaved Caper)

        In  traditional  medicine,  Cortex  Crataeva  Nurvala  is  highly  acclaimed  for  its  use  in  the
        management of urinary tract disorders, especially urolithiasis and in ethnoveterinary medicine
        Cortex Crataeva Nurvala has been used in the treatment of renal lithiasis (Williamson, 2002).
        Pentacyclic triterpenes lupeol and lupeol linoleate isolated from Cortex Crataeva Nurvala, have
        been shown to minimize the deposition of stone-forming components in kidneys (Remya et
        al., 2009) such as calcium, oxalate, urate, cystine, xanthine, and phosphate. Cortex Crataeva
        Nurvala decoction reduces the urinary excretion of sodium and magnesium, shifting values
        from  the  lithogenic  to  the  nonlithogenic  zone  (Deshpande  et al.,  1982).  In  animal  models
        Cortex Crataeva Nurvala extracts have been shown to exert a regulatory action on endogenous
        oxalate synthesis by reducing oxalate-synthesizing liver enzyme, glycolate oxidase (Varalakshmi
        et al., 1990; Patankar et al., 2008).



                 Toxicity for Cortex Crataeva Nurvala has not been documented in dogs and cats when administered orally in
            TOXICOLOGY  adult rats (Williamson, 2002).   50
                 therapeutic doses. Intraperitoneal LD  of Cortex Crataeva Nurvala extract is >1,000 mg/kg of body weight in



                 Equivalent toxic dose in 20 kg dog:   >20,000 mg IP of Cortex Crataeva Nurvala extract.
                 Equivalent toxic dose in 5 kg cat:    >5,000 mg IP of Cortex Crataeva Nurvala extract.


                         DRUG     Validated interactions studies do not exist for Cortex Crataeva Nurvala preparations. Clinical
                INTERACTIONS      interactions with other drugs have not been reported.







                                 Arctostaphylos uva-ursi (Bearberry)


                                 Folium  Uvae  Ursi  is  listed  in The  German  Pharmacopoeia  as  a  urinary  disinfectant  for
                                 the  treatment  of  bladder  and  kidney  catarrh  and  inflammation.  The  European  Scientific
                                 Cooperative  on  Phytotherapy  (ESCOP)  lists  Folium  Uvae  Ursi  as  a  treatment  for
                                 uncomplicated  cystitis  where  antibiotics  are  not  warranted. The  German  Commission  E
                                 Monographs recommends it for inflammatory conditions of the lower urinary tract. Folium
                                 Uvae Ursi has been reported to be a diuretic, bacteriostatic, and astringent and has been
                                 used in the treatment of urinary tract disorders (Martindale, 1996).














        4  |   Nephro -VM TM
   106   107   108   109   110   111   112   113   114   115   116